GENE THERAPY FOR PULMONARY ALVEOLAR PROTEINOSIS

被引：0
|
作者：
Atsumi, N. [1 ]
Pilou, A. [1 ]
Pringle, I. [2 ,3 ]
Ashworth, R. C. [2 ,3 ]
Meng, C. [2 ,4 ]
Chan, M. [2 ,4 ]
Gill, D. R. [2 ,3 ]
Hyde, S. [2 ,3 ]
Morgan, C. [5 ]
Alton, E. W. F. W. [1 ]
Griesenbach, U. [2 ,4 ]
机构：
[1] Imperial Coll London, NHLI, Dept Gene Therapy, London, England
[2] Univ Oxford, Radcliffe Dept Med, London, England
[3] Gene Therapy Consortium, London, England
[4] Imperial Coll London, NHLI, Dept Gene Therapy, London, England
[5] Royal Brompton Hosp, London, England
来源：
THORAX | 2017年 / 72卷
关键词：
D O I：
10.1136/thoraxjnl-2017-210983.126
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S120
引用
收藏
页码：A72 / A73
页数：2
相关论文
共 50 条
  • [1] Gene Therapy for Autoimmune Pulmonary Alveolar Proteinosis
    Juarez-Molina, Claudia I.
    Lund-Palau, Helena
    Meng, Cuixiang
    Gill, Deborah
    Hyde, Stephen
    Alton, Eric
    Griesenbach, Uta
    MOLECULAR THERAPY, 2021, 29 (04) : 256 - 257
  • [2] Lentivirus Gene Therapy for Autoimmune Pulmonary Alveolar Proteinosis
    Palau, Helena
    Meng, Cuixiang
    Bhargava, Anushka
    Pilou, Aikaterini
    Atsumi, Naoko
    Byrne, Adam
    Pringle, Ian
    Ashworth, Rachel
    Chan, Mario
    Gill, Deborah
    Hyde, Stephen
    Morgan, Cliff
    Alton, Eric
    Griesenbach, Uta
    MOLECULAR THERAPY, 2019, 27 (04) : 43 - 44
  • [3] Non-viral Gene Therapy for Autoimmune Pulmonary Alveolar Proteinosis
    Juarez-Molina, C.
    Meng, C.
    Morgan, C.
    Padley, S.
    Gill, D.
    Hyde, S.
    Alton, E. W. F. W.
    Griesenbach, U.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A189 - A189
  • [4] TOTAL PULMONARY LAVAGE IN THERAPY OF ALVEOLAR PROTEINOSIS
    GERASIN, VA
    PALAMARCHUK, GF
    KRASNOGOROV, VA
    ILKOVICH, MM
    ZHURAVLEV, AV
    DEMBO, EM
    TERAPEVTICHESKII ARKHIV, 1986, 58 (12) : 18 - &
  • [5] Rituximab therapy in autoimmune pulmonary alveolar proteinosis
    Borie, R.
    Debray, M-P.
    Laine, C.
    Aubier, M.
    Crestani, B.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (06) : 1503 - 1506
  • [6] Pulmonary alveolar proteinosis: from classification to therapy
    Salvaterra, Elena
    Campo, Ilaria
    BREATHE, 2020, 16 (02) : 1 - 12
  • [7] Efficacy of Rituximab Therapy in Pulmonary Alveolar Proteinosis
    Brescia, D.
    Dalrymple, H.
    Malur, A.
    Arce, S.
    Lucas, A.
    Gagnon, G.
    Marshall, I.
    Barna, B. P.
    Kavuru, M. S.
    Thomassen, M. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [8] Lentivirus GM-CSF gene therapy for autoimmune pulmonary alveolar proteinosis
    Lund-Palau, Helena
    Pilou, Aikaterini
    Atsumi, Naoko
    Pringle, Ian
    Ashworth, R. C.
    Meng, C.
    Chan, Mario
    Gill, Deborah
    Hyde, Stephen
    Morgan, Cliff
    Alton, E. W. F. W.
    Griesenbach, Uta
    HUMAN GENE THERAPY, 2018, 29 (07) : A2 - A2
  • [9] Development of Cell and Gene Therapy Products to Treat Hereditary Pulmonary Alveolar Proteinosis
    Link, Kevin A.
    Suzuki, Takuji
    Carey, Brenna
    Arumugam, Paritha
    Malik, Punam
    Trapnell, Bruce
    Lutzko, Carolyn
    MOLECULAR THERAPY, 2014, 22 : S267 - S267
  • [10] PULMONARY ALVEOLAR PROTEINOSIS
    KURGAN, J
    SMIGLA, K
    RESPIRATION, 1974, 31 (03) : 278 - 286
12345